Literature DB >> 12358904

Tumoral non-amyloidotic monoclonal immunoglobulin light chain deposits ('aggregoma'): presenting feature of B-cell dyscrasia in three cases with immunohistochemical and biochemical analyses.

Agueda Rostagno1, Glauco Frizzera, Lourdes Ylagan, Asok Kumar, Jorge Ghiso, Gloria Gallo.   

Abstract

Tumoral monoclonal immunoglobulin (Ig) light chain non-fibrillar deposits ('aggregomas'), which can be considered analogous to solitary light chain amyloidomas, are a rare presenting feature of B-cell dyscrasias. It is not certain if they are truly localized or if in reality they represent an initial expression of a silent systemic non-amyloid light chain deposition disease (LCDD). This report describes three patients, two of whom presented with cervical masses and the third with a solitary lung nodule, each comprising granular aggregates of monoclonal kappa light chain. Extracted deposits from the lymph node of one patient were shown by N-terminal amino acid sequence analysis to belong to the variable-region kappa I (Vkappa I) light chain subgroup, the first reported kappa-LCDD protein encoded by the L9 gene and the first report of an expressed protein related to this gene. Extracted deposits from the lung nodule of the second patient belonged to the Vkappa IV light chain subgroup encoded by the B3 germ line gene. The N-terminal amino acid sequences of the light chains from the aggregomas were compared with the related germ line sequences and to the N-terminal amino acid sequences of the nine other known kappa-LCDD light chains reported thus far from patients with systemic LCDD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12358904     DOI: 10.1046/j.1365-2141.2002.03781.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

1.  Extraosseus plasmacytoma of the pharynx with localized light chain deposition. Case report.

Authors:  Nina Zidar; Samo Zver; Vesna Jurcić
Journal:  Pathol Oncol Res       Date:  2009-12-05       Impact factor: 3.201

2.  Co-deposition of amyloidogenic immunoglobulin light and heavy chains in localized pulmonary amyloidosis.

Authors:  Batia Kaplan; Brian M Martin; Olga Boykov; Rivka Gal; Mordechai Pras; Itzhak Shechtman; Milton Saute; Mordechai R Kramer
Journal:  Virchows Arch       Date:  2005-10-19       Impact factor: 4.064

3.  Monoclonal gammopathy of undetermined significance with amyloid deposition in the lung and non-amyloid eosinophilic deposition in the brain: a case report.

Authors:  Francois Abi-Fadel; Nisarg R Desai; Gita Vatandoust; Rabih Said; Aaron Gottesman; Terenig Terjanian
Journal:  Case Rep Med       Date:  2010-03-14

4.  Nonamyloid tumoral light-chain-deposition disease (aggregoma) of the paraspinal region.

Authors:  Ayushi Singh; Linda Okonkwo; Jason C Hoffmann; Joseph P Mazzie; Amanjit S Baadh
Journal:  Skeletal Radiol       Date:  2015-08-08       Impact factor: 2.199

5.  Primary cystic lung light chain deposition disease: a clinicopathologic entity derived from unmutated B cells with a stereotyped IGHV4-34/IGKV1 receptor.

Authors:  Magali Colombat; Hervé Mal; Christiane Copie-Bergman; Jacques Diebold; Diane Damotte; Patrice Callard; Michel Fournier; Jean-Pierre Farcet; Marc Stern; Marie-Hélène Delfau-Larue
Journal:  Blood       Date:  2008-05-15       Impact factor: 22.113

6.  A case of isolated light chain deposition disease in the duodenum.

Authors:  Hee-Jun Kim; Eunkyung Park; Tae Jin Lee; Jae Hyuk Do; Young Joo Cha; Sang Jae Lee
Journal:  J Korean Med Sci       Date:  2012-01-27       Impact factor: 2.153

7.  Nodular pulmonary deposition disease in a patient with the acquired immunodeficiency syndrome: a case report.

Authors:  Jessica N Mezzanotte; I-Sanna Gibbons-Fideler; Konstantin Shilo; Mark Lustberg; Srinivas Devarakonda
Journal:  J Med Case Rep       Date:  2020-06-04

8.  Primary cerebral low-grade B-cell lymphoma, monoclonal immunoglobulin deposition disease, cerebral light chain deposition disease and "aggregoma": an update on classification and diagnosis.

Authors:  Marco Skardelly; Georgios Pantazis; Sotirios Bisdas; Guenther C Feigl; Martin U Schuhmann; Marcos S Tatagiba; Rainer Ritz
Journal:  BMC Neurol       Date:  2013-08-15       Impact factor: 2.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.